InsidersTradesSigma
Discover the complete record of transactions filed by McKelligon Brian, Chief Executive Officer. Director active across 1 companies, notably Akoya Biosciences, Inc.. Cumulatively, 2 filings have been published. The latest transaction was disclosed on 15 June 2022 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
2 of 2 declarations
Brian McKelligon is President and CEO of Akoya Biosciences, Inc. He leads the company and is responsible for its overall strategy and operations. His leadership is crucial for the company's innovation and growth.